Pain researcher, cancer drug pioneer win Queensland award

Updated on 31 October 2012

The Award, selected by peer vote for the past four years, is presented to individuals who have made significant contributions to the performance and success of the Queensland life sciences industry

professor-maree-smith-and-dr-jim-aylward-win-2012-life-sciences-queensland-lsq-industry-award-for-excellence

Professor Maree Smith and Dr Jim Aylward win 2012 Life Sciences Queensland (LSQ) Industry Award for Excellence

Singapore: Professor Maree Smith, the pain research innovator behind successful UniQuest start-ups QRxPharma and Spinifex Pharmaceuticals, has been awarded a 2012 Life Sciences Queensland (LSQ) Industry Award for Excellence.

The award, selected by peer vote, is presented to individuals who have made "significant contributions to the performance and success of the Queensland life sciences industry" and "demonstrated a breadth of impact across the sector in Queensland".

Congratulating Professor Smith on this latest honour, UniQuest MD, Dr David Henderson, said that, "New drugs based on Professor Smith's discoveries are close to market-ready, and that's not only because of the quality and volume of her scientific endeavour but is also because she has played an active and integral role in the global biotech industry to accelerate access to a whole new approach to pain management."

Professor Smith shared the LSQ Industry Excellence Award with Dr Jim Aylward, who patented Australia's first FDA-approved cancer chemotherapeutic drug. The awards were presented in the presence of Her Excellency, Ms Penelope Wensley AC, the Governor of Queensland and the Patron of LSQ at the Life Sciences Queensland Globally Engaging Network Event (GENE) on October 26, 2012.

 

 

Leave a Reply

Post Comment

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X